Major Indian Pharmas Seek Deals With MNCs To Collaborate On Phase III Work (India)
This article was originally published in PharmAsia News
Executive Summary
Major Indian pharmaceutical companies, in an apparent strategy change, plan to seek collaboration agreements with multinational drug makers on Phase III research. Indian firms such as Dr. Reddy's Laboratory, Nicholas Piramat, Sun Pharma and Wockhardt are attempting to add to their pipelines of new chemical entities. The strategy includes commercializing drugs in the West under contracts that would give the Indian firms larger milestone payments. Analysts say the strategy change is driven by a need for new revenue streams. (Click here for more